|Passed by the Senate March 1, 2011|
President of the Senate
Passed by the House April 1, 2011
Speaker of the House of Representatives
I, Thomas Hoemann, Secretary of the Senate of the State of Washington, do hereby certify that the attached is ENGROSSED SUBSTITUTE SENATE BILL 5594 as passed by the Senate and the House of Representatives on the dates hereon set forth.
Governor of the State of Washington
Secretary of State
State of Washington
|State of Washington||62nd Legislature||2011 Regular Session|
READ FIRST TIME 02/14/11.
AN ACT Relating to handling of hazardous drugs; adding new sections to chapter 49.17 RCW; and creating a new section.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:
NEW SECTION. Sec. 1 The legislature declares that health care
personnel who work with or near hazardous drugs in health care settings
may be exposed to these agents in the air, on work surfaces, clothing,
and medical equipment or through patient contact. According to the
national institute for occupational safety and health (NIOSH), early
concerns about occupational exposure to antineoplastic drugs first
appeared in the 1970s. Antineoplastic and other hazardous drugs may
cause skin rashes, infertility, miscarriage, birth defects, and have
been linked to a wide variety of cancers. The national institute for
occupational safety and health published an alert on preventing
occupational exposures to antineoplastic and other hazardous drugs in
health care settings in 2004 with an update in 2010. In this alert,
the institute "presents a standard precautions or universal precautions
approach to handling hazardous drugs safely: that is, NIOSH recommends
that all hazardous drugs be handled as outlined in this Alert." It is
the intent of the legislature to require health care facilities to
follow rules requiring compliance with all aspects of the institute's
alert regardless of the setting in order to protect health care
personnel from hazardous exposure to such drugs.
NEW SECTION. Sec. 2 A new section is added to chapter 49.17 RCW
to read as follows:
The definitions in this section apply throughout sections 1 through 3 of this act unless the context clearly requires otherwise.
(1) "Antineoplastic drug" means a chemotherapeutic agent that controls or kills cancer cells.
(2) "Hazardous drugs" means any drug identified by the national institute for occupational safety and health at the centers for disease control or any drug that meets at least one of the following six criteria: Carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity in humans, organ toxicity at low doses in humans or animals, genotoxicity, or new drugs that mimic existing hazardous drugs in structure or toxicity.
NEW SECTION. Sec. 3 A new section is added to chapter 49.17 RCW
to read as follows:
The director of labor and industries shall adopt by rule requirements for the handling of antineoplastic and other hazardous drugs in health care facilities regardless of the setting. Rule making under this section shall consider input from hospitals, organizations representing health care personnel, other stakeholders and shall consider reasonable time for facilities to implement new requirements. The rules will be consistent with and not exceed provisions adopted by the national institute for occupational safety and health's 2004 alert on preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings as updated in 2010. The department's adoption of the rules may incorporate updates and changes to the institute's guidelines as made by the centers for disease control and prevention. Enforcement of these requirements will be according to all provisions in this chapter.